Page last updated: 2024-08-25

lotrafiban and Stroke

lotrafiban has been researched along with Stroke in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salam, AM1
Amarenco, P; Califf, R; Chan, R; Davis, S; Diener, HC; Easton, JD; Ferguson, J; Fitzgerald, D; Graffagnino, C; Granett, J; Harrington, R; Ilson, B; Koudstaal, PJ; Samuels, R; Shuaib, A; Theroux, P; Topol, EJ; Van de Werf, F; Willerson, JT1
SoRelle, R1

Trials

1 trial(s) available for lotrafiban and Stroke

ArticleYear
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
    American heart journal, 2000, Volume: 139, Issue:6

    Topics: Administration, Oral; Adolescent; Arterial Occlusive Diseases; Benzodiazepines; Double-Blind Method; Drug Evaluation; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Myocardial Ischemia; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Research Design; Secondary Prevention; Stroke

2000

Other Studies

2 other study(ies) available for lotrafiban and Stroke

ArticleYear
Is there a role for oral blockade of platelet glycoprotein IIb/IIIa receptors in coronary and cerebrovascular disease?
    Expert opinion on investigational drugs, 2003, Volume: 12, Issue:10

    Topics: Administration, Oral; Benzodiazepines; Coronary Disease; Humans; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stroke

2003
SmithKline Beecham halts tests of lotrafiban, an oral glycoprotein IIb/IIIa inhibitor.
    Circulation, 2001, Jan-02, Volume: 103, Issue:1

    Topics: Administration, Oral; Benzodiazepines; Clinical Trials, Phase III as Topic; Hemorrhage; Humans; Myocardial Infarction; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Treatment Outcome

2001